Trial NCT04231864

View at ClinicalTrials.gov 
Org. Study IDs: 18209
Secondary IDs: NCI-2019-06736

Last trial update was posted on 2020-10-26

MeSH Interventions

Antibodies, Monoclonal Durvalumab Immunoglobulin G Immunoglobulins

MeSH Conditions

Carcinoma Epstein-Barr Virus Infections Nasopharyngeal Carcinoma Recurrence

Other Conditions

Epstein-Barr Virus Positive Metastatic Nasopharyngeal Carcinoma Recurrent Nasopharyngeal Carcinoma Stage III Nasopharyngeal Carcinoma Stage IV Nasopharyngeal Carcinoma Stage IVA Nasopharyngeal Carcinoma Stage IVB Nasopharyngeal Carcinoma

Stopping Reasons

Feasibility

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID